Risk-Taking Investors May Find Sunshine Biopharma Inc (NASDAQ: SBFM) Worth A Gamble.


In today’s recent session, 15.29 million shares of the Sunshine Biopharma Inc (NASDAQ:SBFM) have been traded, and its beta is -1.15. Most recently the company’s share price was $0.08, and it changed around -$0.03 or -21.78% from the last close, which brings the market valuation of the company to $8.28M. SBFM at last check was trading at a discount to its 52-week high of $1.40, offering almost -1650.0% off that amount. The share price’s 52-week low was $0.04, which indicates that the recent value has risen by an impressive 50.0% since then. We note from Sunshine Biopharma Inc’s average daily trading volume that its 10-day average is 35.26 million shares, with the 3-month average coming to 20.73 million.

Sunshine Biopharma Inc (NASDAQ:SBFM) trade information

Instantly SBFM has been showing red trend so far today with a performance of -21.78% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently down -69.32% year-to-date, but still up 44.62% over the last five days. On the other hand, Sunshine Biopharma Inc (NASDAQ:SBFM) is 50.36% up in the 30-day period. We can see from the shorts that 0.97 million shares have been sold at a short interest cover period of 0.02 day(s).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sunshine Biopharma Inc (SBFM) estimates and forecasts

The year-over-year growth rate is expected to be 84.30%, up from the previous year.

Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $7 million in revenue for the current quarter. 1 analysts expect Sunshine Biopharma Inc to make $9 million in revenue for the quarter ending Jun 2024.

Sunshine Biopharma Inc (NASDAQ:SBFM)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 9.45% of Sunshine Biopharma Inc shares, and 6.51% of them are in the hands of institutional investors. The stock currently has a share float of 7.19%. Sunshine Biopharma Inc stock is held by 17 institutions, with Armistice Capital, LLC being the largest institutional investor. By Jun 29, 2023, it held 0.42% of the shares, which is about 2.19 million shares worth $1.08 million.

Bridgeway Capital Management, Inc., with 0.06% or 0.29 million shares worth $0.14 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.

The former held 0.29 million shares worth $0.14 million, making up 0.06% of all outstanding shares.